ReviewHematology/oncology clinics of North America2021

First-Line Therapy for Chronic Lymphocytic Leukemia: Bruton Tyrosine Kinase or BCL2 or Both?

Hua-Jay J Cherng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.